Disease Prevention and Control Project

closed

The development objective of the Disease Prevention and Control Project for Armenia is to improve (i) Maternal and Child Health (MCH) services and the prevention, early detection, and management of selected Non-Communicable Diseases (NCD) at the Primary Health Care (PHC) level; and (ii) the efficiency and quality of selected hospitals in Armenia. The project has three components. Component 1 is Performance-based Financing (PBF) scheme to improve MCH and NCD services in primary care facilities (US$4.3 million, of which US$1.8 million from the Health Results Innovation Trust Fund (HRITF) Grant). This component will support the strengthening of the on-going primary health care Performance-based Financing (PBF) program in Armenia as well as expanding its scope. It comprises two sub-components as follows: (1) performance-based payments for MCH and NCD (US$ 3.5million); and (2) performance-based financing implementation and capacity building (US$ 0.8 million). The second component is improving efficiency and quality of selected hospitals (US$38.9 million). This component aims at improving further efficiency and quality of hospital services provision in Armenia by supporting hospital optimization in the only remaining region and improving infrastructure and treatment capacity at selected specialized tertiary level mono-profile hospitals. It comprises four subcomponents as follows: (1) modernization of Lori Marz hospital network (US$13.0 million); (2) modernization of Center of Hematology named after Professor Yeolyan CJSC (US$13.0 million); (3) modernization of cancer treatment services in Armenia (US$12.4 million); and (4) hospital quality improvement (US$0.5million). The third component is project management (US$1.8 million). It will finance project operating costs, including inter-alia translation, interpretation, equipment, supervision costs (transportation and per diem), staffing costs of the Health Project Implementation Unit (HPIU), monitoring and evaluation (M and E) studies and surveys, incremental costs at the Ministry of Health (MoH), and audits of project financial statements.